Results 11 to 20 of about 15,379 (248)

Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single‐Center Series of Outcomes and Complications [PDF]

Chest, 2019
BACKGROUND: Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases, transjugular intrahepatic portosystemic shunt and liver transplantation may be required.
C. Kniese, K. Diab, M. Ghabril, G. Bosslet   +3 more
semanticscholar   +4 more sources

A Rare Presentation of Right-Sided Pleural Effusion in Decompensated Chronic Liver Disease Secondary to Hepatitis C Infection: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Hepatic hydrothorax (HH) is an infrequent and clinically important complication of decompensated liver cirrhosis. It occurs in around 5%–10% of affected people. Hepatic hydrothorax is basically a transudative pleural effusion, usually right‐sided and commonly without evidence of primary cardiopulmonary or renal pathology.
Siddiq N, Rauf NF, Javaid MH, Cheema ZZ, Ali R, Mahato RK.   +5 more
europepmc   +2 more sources

Comparison of Insertion Difficulties and Performance of Thoracoamniotic Shunts for Fetal Hydrothorax: Success and Failure Rates in Different Shunt Types for Fetal Hydrothorax. [PDF]

Prenat Diagn
ABSTRACT Objective This study compared insertion difficulties, shunt failure, reintervention rates, maternal adverse events, and neonatal outcomes among different shunt types used in fetal hydrothorax. Method A retrospective multicenter cohort study (2012–2022) was conducted across 12 international centers.
Treurniet TT, Abbasi N, Ryan G, Witlox RSGM, Slaghekke F, Nørgaard LN, Sundberg K, Lindgren P, Ek S, Thilaganathan B, Blayney G, Devlieger R, Lewi L, Johnson A, Pacora Portella PN, David AL, Vieira M, Khalil A, Poljak B, Vonzun L, Ochsenbein-Koelble N, Choolani M, Gosavi A, Moise KJ, Hutson E, Verweij EJTJ, Haak MC.   +26 more
europepmc   +2 more sources

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax

Journal of Clinical Medicine, 2023
Problem: Does the presence of hydrothorax suggest that severe ovarian hyperstimulation syndrome (OHSS) is associated with more severe conditions and worse pregnancy outcomes?
Xiaowei Ma, Jin Yin, Rui Yang, Shuo Yang, Jia Li, Yang Wang, Rong Li   +6 more
semanticscholar   +1 more source

International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations

BMC Gastroenterology, 2023
Background The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult.
Jean-François Cadranel, I. Ollivier-Hourmand, J. Cadranel, T. Thévenot, H. Zougmoré, E. Nguyen-Khac, C. Bureau, M. Allaire, J. Nousbaum, V. Loustaud-Ratti, Xavier Causse, P. Sogni, B. Hanslik, M. Bourlière, J. Peron, N. Ganne-Carrié, T. Dao, D. Thabut, Bernard Maitre, Nabil Debzi, Ryad Smadhi, R. Sombié, Raimi Kpossou, O. Nouel, Julien Bissonnette, Isaac Ruiz, Mourad Medmoun, S. Dastis, P. Deltenre, Florent Artru, Chantal Raherison, L. Elkrief, Tristan Lemagoarou   +32 more
semanticscholar   +1 more source

Hepatic Hydrothorax: A Narrative Review

Pulmonary Therapy, 2022
Hepatic hydrothorax (HH) represents a distinct clinical entity within the broader classification of pleural effusion that is associated with significant morbidity and mortality. The median survival of patients with cirrhosis who develop HH is 8–12 months.
B. Pippard, M. Bhatnagar, L. McNeill, M. Donnelly, K. Frew, A. Aujayeb   +5 more
semanticscholar   +1 more source

Intrauterine Thoracoamniotic Shunting of Fetal Hydrothorax with the Somatex Intrauterine Shunt: Intrauterine Course and Postnatal Outcome

Journal of Clinical Medicine, 2022
(1) Background: Severe fetal hydrothorax can be treated by intrauterine thoracoamniotic shunting (TAS). The aim of this study was to assess perinatal outcome and complication rates of TAS with a novel Somatex intrauterine shunt.
Joleen Grandt, I. Gottschalk, A. Geipel, U. Gembruch, C. Simonini, E. Weber, C. Berg, A. Müller, B. Strizek   +8 more
semanticscholar   +1 more source

Evaluating factors associated with the risk of hydrothorax following standard supracostal percutaneous nephrolithotomy

Asian Journal of Urology, 2022
Objective: To report our experience with supracostal percutaneous nephrolithotomy (SC-PNL) and evaluate factors which could predict the risk of hydrothorax following SC-PNL.
Pankaj N. Maheshwari, Amandeep Arora, Mahesh S. Sane, Vivek Jadhao   +3 more
doaj   +1 more source

Use of Octreotide in Chylothorax With Mediastinal Mass of Unknown Behaviour: A Case Report. [PDF]

Respirol Case Rep
A 37‐year‐old woman with chylothorax and a mediastinal mass of uncertain behaviour had persistent pleural drainage despite initial interventions and unavailable advanced options. Octreotide infusion resulted in a marked reduction of drainage and complete resolution.
Geronimo AJ, Monis M.
europepmc   +2 more sources

Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients

European Radiology, 2022
Objectives Hepatic hydrothorax (HH) is a predictor of poor survival in cirrhosis patients. However, whether HH increases the mortality risk of cirrhosis patients treated with transjugular intrahepatic portosystemic shunt (TIPS) is unknown.
X. Gou, Wenyuan Jia, Chuang-ye He, Xulong Yuan, J. Niu, Jiao Xu, N. Han, Ying Zhu, Wen-liang Wang, J. Tie   +9 more
semanticscholar   +1 more source